Prognostic models for 9 month mortality in tuberculous meningitis.

Prognostic models for 9 month mortality in tuberculous meningitis.

<h4>Background</h4> <p>Tuberculous meningitis (TBM) is the most severe form of extrapulmonary tuberculosis. We developed and validated prognostic models for 9-month mortality in adults with TBM, with or without human immunodeficiency virus (HIV) infection.</p> <h4>Meth...

Full description

Bibliographic Details
Main Authors:	Thao, L, Heemskerk, A, Geskus, R, Mai, N, Ha, D, Chau, T, Phu, N, Chau, N, Caws, M, Lan, N, Thu, D, Thuong, N, Day, J, Farrar, J, Torok, M, Bang, N, Thwaites, G, Wolbers, M
Format:	Journal article
Language:	English
Published:	Oxford University Press 2017

Similar Items

Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis.
by: Nhu, N, et al.
Published: (2014)

Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis
by: Nhu, N, et al.
Published: (2014)

Dynamic prediction of death in patients with tuberculous meningitis using time-updated Glasgow coma score and plasma sodium measurements
by: Thao, L, et al.
Published: (2019)

Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
by: Thuong, N, et al.
Published: (2017)

Intensified antituberculosis therapy in adults with tuberculous meningitis
by: Heemskerk, AD, et al.
Published: (2016)

Sample size requirements for separating out the effects of combination treatments: randomised controlled trials of combination therapy vs. standard treatment compared to factorial designs for patients with tuberculous meningitis.
by: Wolbers, M, et al.
Published: (2011)

Tuberculous meningitis.
by: Thwaites, G, et al.
Published: (2000)

Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis.
by: Tho, D, et al.
Published: (2012)

Therapy for tuberculous meningitis
by: Heemskerk, A, et al.
Published: (2016)

Validation of a diagnostic algorithm for adult tuberculous meningitis.
by: Török, M, et al.
Published: (2007)

Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
by: Heemskerk, D, et al.
Published: (2011)

Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis.
by: Thwaites, G, et al.
Published: (2002)

Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults.
by: Torok, M, et al.
Published: (2008)

A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults
by: Mai, N, et al.
Published: (2018)

Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
by: Thwaites, G, et al.
Published: (2011)

Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study
by: Bang, N, et al.
Published: (2016)

Improving the bacteriological diagnosis of tuberculous meningitis.
by: Thwaites, G, et al.
Published: (2004)

Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy.
by: Thwaites, G, et al.
Published: (2004)

Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features.
by: Thwaites, G, et al.
Published: (2002)

Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis
by: Thwaites, G, et al.
Published: (2003)

Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis.
by: Thwaites, G, et al.
Published: (2003)

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
by: Török, M, et al.
Published: (2011)

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)–associated tuberculous meningitis
by: Török, M, et al.
Published: (2011)

Adjunctive dexamethasone for the treatment of HIV-uninfected adults with tuberculous meningitis stratified by Leukotriene A4 hydrolase genotype (LAST ACT): Study protocol for a randomised double blind placebo controlled non-inferiority trial
by: Donovan, J, et al.
Published: (2018)

A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis.
by: Thuong, N, et al.
Published: (2007)

Pretreatment cerebrospinal fluid bacterial load correlates with inflammatory response and predicts neurological events during tuberculous meningitis treatment
by: Thuong, NTT, et al.
Published: (2018)

Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome.
by: Simmons, C, et al.
Published: (2006)

Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome
by: Simmons, C, et al.
Published: (2006)

The neurocritical care of tuberculous meningitis
by: Donovan, J, et al.
Published: (2019)

A novel diagnostic model for tuberculous meningitis using Bayesian latent class analysis
by: Dong, THK, et al.
Published: (2024)

Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adult
by: Donovan, J, et al.
Published: (2023)

Pharmacokinetics and pharmacodynamics of intensive antituberculosis treatment of tuberculous meningitis
by: Ding, J, et al.
Published: (2020)

Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis.
by: Caws, M, et al.
Published: (2007)

Recent advances in the diagnosis and management of tuberculous meningitis.
by: Mai, N, et al.
Published: (2016)

The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses.
by: Simmons, C, et al.
Published: (2005)

The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses
by: Simmons, C, et al.
Published: (2005)

Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen
by: Heemskerk, A, et al.
Published: (2017)

Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
by: Torok, M, et al.
Published: (2011)

Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
by: Török, M, et al.
Published: (2011)

Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis.
by: Thwaites, G, et al.
Published: (2005)